Code | 2026E | ||||||||||
MA number | 59/0246/22-S | ||||||||||
Product Form: | tbl flm 252x267 mg (blis.PVC/PCTFE/Al-neperfor.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 30 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 19.09.2022 |
Validity: | 19.09.2027 |
SPC: | SPC_Pirfenidone Zentiva_tbl flm_11.2023.pdf |
PIL: | PIL_Pirfenidone Zentiva_tbl flm_11.2023.pdf |
Safety feature | Yes |
Data update: | 21.09.2022 |